Galderma Launches Alastin ® in China, Supporting the Skin’s Natural Regenerative Abilities in a Rapidly Expanding Market
Galderma (SIX: GALD) today announced the launch of four core Alastin® products in China, marking the premium medical skincare brand’s debut in one of the world’s fastest growing aesthetic skincare markets.6-8 This is the first launch to feature Alastin by Galderma’s new re-energized, premium look and feel, a bold evolution that reflects its leadership in perioperative skincare.
Alastin offers full-spectrum care for patients undergoing aesthetic procedures, from pre-treatment preparation to post-treatment recovery and at-home maintenance, supporting the skin’s natural regenerative abilities to improve overall skincare results.1,2,9-13 With over 50 global dermatological publications and 22 patents, Alastin is strongly backed by science and is the number one peri-procedural skincare brand in the United States.14-16 This launch follows the strong growth of Alastin in other key markets and demonstrates Galderma’s commitment to addressing the needs of patients with science-backed solutions.
“With Alastin by Galderma, we have a comprehensive perioperative solution to enhance skin recovery around aesthetic treatment and maintenance programs that bring together Galderma’s leading expertise in Dermatological Skincare and Injectable Aesthetics. As the Asia-Pacific region’s beauty and aesthetics market continues to grow at pace, we’re proud to bring Alastin to patients in China who are seeking advanced solutions to support them in their aesthetic journeys.”
|
Comprehensive perioperative solutions addressing growing needs
Four core Alastin products that cover all stages of the aesthetic treatment process will now be available in China, creating an integrated in-clinic and at-home skincare program:
- Regenerating Skin Nectar to optimize visible treatment results9
- HA (Hyaluronic Acid) IMMERSE Serum™ to hydrate and support skin barrier repair10
- INhance Serum helps to enable quicker recovery after treatment with injectables, improving the appearance of the skin post-injection11
- Restorative Skin Complex to support aesthetic treatment results by helping to reduce the visible signs of aging12
This comprehensive perioperative series of regenerative skincare products advances aesthetic treatments from isolated procedures to full-spectrum management.1,2,9-12 It reflects Galderma’s holistic approach to aesthetic care – working across its Dermatological Skincare and Injectable Aesthetics portfolios to ensure that products complement each other, delivering seamless, science-backed solutions that elevate patient outcomes.1,2,9-13 Select products are powered by proprietary TriHex Technology® to further enhance skin regeneration and recovery.1,2,13
China’s medical aesthetics market is experiencing remarkable growth, and is projected to increase by up to 15% in the next decade.17 As aesthetic treatments become increasingly mainstream there is rising demand for perioperative skincare, with consumers willing to invest in advanced technologies and premium products to achieve optimal aesthetic outcomes.3-6,17 With its proven efficacy and full-spectrum approach to pre- and post-procedure care, as well as at-home maintenance, Alastin by Galderma is uniquely positioned to address this need.1,2,6-9
“We’re seeing an incredible rise in demand for aesthetic procedures in China, and with that comes a growing need for effective perioperative skincare. Alastin by Galderma brings a scientifically advanced approach to skin recovery, and I’m excited to see Chinese patients gain access to products that can truly support their skin before and after treatment, and elevate their overall results.”
|
This launch marks ten years of pioneering innovation with Alastin, demonstrating Galderma’s commitment to purposeful growth with the brand’s refreshed premium look and feel, and entry into one of the fastest growing aesthetic skincare markets. Following strong growth in North America, Latin America, Australia, and the U.K. & Ireland, Alastin is now undergoing rapid international expansion, offering its premium products to even more patients. By identifying emerging patient needs and delivering science-backed solutions, Galderma continues to shape the future of dermatology and elevate outcomes across the aesthetic journey.
About Galderma
Galderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: www.galderma.com.
References | |
1. | Widgerow AD, et al. Extracellular Matrix Modulation: Optimizing Skin Care and Rejuvenation Procedures. J Drugs Dermaol. 2016;15(Suppl 4):s63–71. |
2. | Widgerow AD, et al. Preoperative Skin Conditioning: Extracellular Matrix Clearance and Skin Bed Preparation, A New Paradigm. Aesthetic Surgery Journal 2019;39(Suppl 3):s103–11. doi:10.1093/asj/sjz022 |
3. | Guidepoint Qsight. From Gen Z to GLP-1s: Trends Reshaping the Medical Aesthetics Industry. Accessed September 2025. Available online. |
4. | Verified Market Reports. Preoperative Skin Preparation Market. Accessed September 2025. Available online. |
5. | PW Consulting Health Care Research Center. Post Procedure Skin Care Product Market. Accessed September 2025. Available online. |
6. | Kwon SH, et al. Experiences and attitudes toward aesthetic procedures in East Asia: a cross-sectional survey of five geographical regions. Arch Plast Surg. 2021;48(6):660-669. doi: 10.5999/aps.2020.02565. |
7. | Fortune Business Insights. China Skincare Market Size, Share & Industry Analysis. Accessed September 2025. Available online. |
8. | Mordor Intelligence. China Cosmetic Products Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030). Accessed September 2025. Available online. |
9. | Alastin. Regenerating Skin Nectar with TriHex Technology®. Accessed September 2025. Available online. |
10. | Alastin. HA (Hyaluronic Acid) IMMERSE Serum™. Accessed September 2025. Available online. |
11. | Alastin. INhance Post-Injection Serum with TriHex Technology®. Accessed September 2025. Available online. |
12. | Alastin. Restorative Skin Complex with TriHex Technology®. Accessed September 2025. Available online. |
13. | Lee WW, et al. A Multi-Center Evaluation of Restorative Eye Treatment and INhance With Trihex Technology to Improve Aesthetic Outcomes When Used Pre- and Post-Blepharoplasty. Aesthet Surg J Open Forum. 2022 Dec 14;5:ojac089. doi: 10.1093/asjof/ojac089. |
14. | Galderma. Data on File. Alastin Publication List. |
15. | Galderma. Data on File. Alastin Patent List. |
16. | Galderma. Data on File. LifeSci Consulting Primary Market Research. 2022. |
17. | Chameleon Pharma. China’s Dynamic Aesthetic Medicine Market: Outlook, Trends, and Opportunities. Accessed September 2025. Available online. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20250909403223/en/
Contacts
For further information:
Christian Marcoux, M.Sc.
Chief Communications Officer
christian.marcoux@galderma.com
+41 76 315 26 50
Richard Harbinson
Corporate Communications Director
richard.harbinson@galderma.com
+41 76 210 60 62
Céline Buguet
Franchises and R&D Communications Director
celine.buguet@galderma.com
+41 76 249 90 87
Emil Ivanov
Head of Strategy, Investor Relations, and ESG
emil.ivanov@galderma.com
+41 21 642 78 12
Jessica Cohen
Investor Relations and Strategy Director
jessica.cohen@galderma.com
+41 21 642 76 43
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ROYC, Elvinger Hoss, and GDA: Strategic Fund Architecture – Capturing the Next Wave of Private Capital10.9.2025 10:45:00 EEST | Press release
ROYC, together with leading law firms Elvinger Hoss and GDA, today announced the publication of a joint white paper, Strategic Fund Architecture – Capturing the Next Wave of Private Capital. The report offers General Partners (GPs) and asset managers a practical roadmap to navigate Europe’s rapidly evolving fund structuring and distribution landscape. With ELTIF 2.0 now in force, AIFMD II implementation approaching, and the EU’s Savings & Investments Union (SIU) expected to channel trillions of euros of household savings into long-term private markets, fund structuring has become a board-level strategic priority. “Fund structuring is no longer just a back-office concern. Operational platforms and technology are now decisive in determining capital access, speed-to-market, and GP profitability,” said Mathias Leijon, Founder & President at ROYC. “This paper shows how integrating legal, operational, and technology architecture from day one transforms fund formation and lifecycle management
Mobileum and Telkomsel Partner to Deliver Scalable, AI-Powered Insights for Indonesian Enterprises10.9.2025 10:00:00 EEST | Press release
Mobileum Inc. (“Mobileum”), a leading global provider of analytics and network solutions, and PT Telekomunikasi Selular (“Telkomsel”), the leading digital telecommunication service provider in Indonesia and Southeast Asia region, today announced a strategic partnership to deliver high-impact, AI data-driven solutions that help Indonesian enterprises unlock growth, drive innovation, and improve operational efficiency. The partnership combines Mobileum’s expertise in transforming massive, complex telco data insights, into real-time, multi-dimensional AI insights with Telkomsel’s leadership in driving Indonesia’s digital transformation. By leveraging Telkomsel’s customer-centric B2C services and innovative B2B offerings, including IoT and Big Data, the collaboration empowers cross-sector innovation. Together, the companies will equip enterprises, including SuperApp providers and digital service platforms, with the intelligence to personalize experiences, optimize engagement, and scale eff
Stonebranch Acquires HONICO to Strengthen Leadership in SAP Automation10.9.2025 09:00:00 EEST | Press release
Stonebranch, a leading provider of service orchestration and automation platforms (SOAP), today announced the acquisition of HONICO Systems, a recognized pioneer in SAP automation. This strategic move unites Stonebranch with HONICO’s SAP-native technology to deliver the most comprehensive, hybrid-ready SAP automation solution available today. HONICO is best known for its flagship solution, BatchMan, an advanced workload automation platform purpose-built for SAP landscapes. BatchMan enables organizations to manage complex SAP jobs with ease, delivering improved visibility, control, and automation across mission-critical SAP business processes. “This acquisition marks a significant milestone for Stonebranch as we continue to expand our leadership in the SOAP market,” said Stonebranch CEO Giuseppe Damiani. “HONICO’s unparalleled expertise in SAP automation complements our vision of delivering end-to-end orchestration across all enterprise systems. Together, we’re providing our customers w
Avanzanite Bioscience Welcomes Dr. Mark Bechter as SVP Medical Affairs10.9.2025 08:00:00 EEST | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial stage European specialty pharmaceutical company focused on rare diseases, announced today the appointment of Dr. Mark Bechter as Senior Vice President of Medical Affairs. As the sixth executive leadership hire of 2025, this appointment further strengthens Avanzanite’s “Champions League” team. It also underscores the company’s commitment to breaking barriers to bring rare disease medicines to patients in every corner of Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250909370704/en/ Mark Bechter, SVP Head of Medical Affairs “I am thrilled to join the Avanzanite team and contribute to our ethos of uncovering potential and setting new standards to make a lasting difference in the lives of rare disease patients,” said Dr. Bechter. “I am particularly excited to be part of a company where my personal values and those of the corporation align so perfectly.” Having gra
Strategy x Super Speed x Showdown -- New Competitive Puzzle Game “SHIKA-Q” to Launch Worldwide in Fall 202510.9.2025 07:00:00 EEST | Press release
AGNI-FLARE CO., LTD. (Headquarters: Yokohama, Kanagawa) today announced that its new online competitive puzzle game “SHIKA-Q” will be released worldwide (excluding certain regions) in Fall 2025 for Nintendo Switch, PlayStation®4, and PlayStation®5. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250828701219/en/ “SHIKA-Q” Game Title Logo SHIKA-Q is an online, real-time puzzle battle played on a 10x10 board where players link blocks to launch rapid-fire attacks and defenses. At the core of the gameplay is music—not merely background sound, but original vocal tracks created to symbolize the battle, delivering an unprecedented sense of immersion. Key Features Strategy x Super Speed x Showdown. Real-time puzzle battles where instant decisions determine victory, akin to a fighting game. Music at the Heart of Gameplay. Each battle is driven by original vocal tracks, a core element of the experience. Character songs heighten tension
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom